Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Palantir Technologies

- PMLiVE

New hope for castration-resistant prostate cancer

An unprecedented number of therapies have reached late-stage clinical trials or been approved over recent years targeting this disease with an unmet medical need

- PMLiVE

Good practice in cancer care recognised at UK awards

Sir Mike Richards honoured with lifetime achievement award at QiC Excellence in Oncology 2012

- PMLiVE

Moving with the times: pharma market research and digital

As digital technology continues to transform the world around us, pharmaceutical market researchers are harnessing its potential to capture vital insights from healthcare stakeholders

- PMLiVE

EFPIA offers to cap Greek drug costs as debts escalate

Comes as Merck KGaA halts Erbitux supplies over unpaid bills

- PMLiVE

Menarini signs €800m cancer antibody deal

Will work with Oxford BioTherapeutics on antibody-drug conjugates

- PMLiVE

FDA approves Teva’s leukaemia drug Synribo

Accelerated approval means early competition for Pfizer’s Bosulif

- PMLiVE

Ruder Finn focuses on mHealth with new healthcare tech division

Will begin with a team of four led by Emma Sinden

- PMLiVE

Abbott and Seattle expand antibody-drug conjugate collaboration

Pharma company could pay $220m per oncology target

Think differently about digital strategy

Why the change to digital communications means we need a different strategic approach

- PMLiVE

How to choose your social media platform

One of the most important factors to consider is the localisation of your audience

Bayer’s former oncology head Robert Rosen joins AP Pharma

Will lead launch of drug to prevent chemotherapy-induced nausea

- PMLiVE

Are you really listening or just waiting to speak?

A modern social listening programme can indentify people’s motivations and information needs

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links